FDA approves new high dose Spinraza regimen for SMA
1st April 2026 Uncategorised 0Updated dosing offers meaningful clinical benefit More: FDA approves new high dose Spinraza regimen for SMA Source: News
read more
Updated dosing offers meaningful clinical benefit More: FDA approves new high dose Spinraza regimen for SMA Source: News
read more
Company says treatment shows strong efficacy and convenient dosing profile More: Viridian reports positive results from elegrobart phase 3 trial Source: News
read moreThe FDA has approved Lilly’s GLP-1 receptor agonist pill as the first new molecular entity cleared under the regulator’s controversial Commissioner’s National Priority Voucher program. More: Lilly answers Novo's GLP-1 pill with highly anticipated FDA nod for Foundayo Source: fierce
read moreThe National Institute for Health and Care Excellence, which serves as the U.K.’s drug price regulator, has given the green light to Wegovy (semaglutide) as a weekly injection to prevent heart attacks and strokes. The endorsement is separate from Wegovy’s
read moreEvotec has appointed Ashiq Khan, Ph.D., as chief commercial officer, putting an executive with robotics and artificial intelligence experience in charge of a unit that is central to the company’s recently unveiled transformation plan. More: Evotec hires exec with AI
read moreHave we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the figures. More: ‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1 Source:
read more© 1994 - 2026 B.M. Pharmaceuticals